Beacon Capital Management LLC Has $1.34 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Beacon Capital Management LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,429 shares of the company’s stock after selling 46 shares during the period. HCA Healthcare makes up approximately 0.4% of Beacon Capital Management LLC’s investment portfolio, making the stock its 24th largest position. Beacon Capital Management LLC’s holdings in HCA Healthcare were worth $1,344,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its stake in shares of HCA Healthcare by 13.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 7,974,024 shares of the company’s stock valued at $2,102,591,000 after acquiring an additional 934,406 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of HCA Healthcare by 1.7% in the 1st quarter. Geode Capital Management LLC now owns 3,812,961 shares of the company’s stock valued at $1,002,773,000 after purchasing an additional 64,029 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of HCA Healthcare by 14.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,800,847 shares of the company’s stock valued at $701,948,000 after purchasing an additional 347,177 shares in the last quarter. Longview Partners Guernsey LTD increased its stake in HCA Healthcare by 3.0% in the first quarter. Longview Partners Guernsey LTD now owns 2,602,832 shares of the company’s stock valued at $686,315,000 after purchasing an additional 76,669 shares in the last quarter. Finally, Norges Bank bought a new stake in HCA Healthcare during the 4th quarter valued at $547,104,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 0.2 %

Shares of HCA traded down $0.57 during mid-day trading on Tuesday, reaching $255.14. The company had a trading volume of 82,593 shares, compared to its average volume of 1,283,260. The firm has a 50-day moving average price of $276.42 and a 200 day moving average price of $274.08. The company has a market capitalization of $69.40 billion, a price-to-earnings ratio of 12.58, a price-to-earnings-growth ratio of 1.32 and a beta of 1.60. HCA Healthcare, Inc. has a 52 week low of $178.32 and a 52 week high of $304.86. The company has a debt-to-equity ratio of 79.26, a quick ratio of 1.03 and a current ratio of 1.20.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Thursday, July 27th. The company reported $4.29 earnings per share for the quarter, beating analysts’ consensus estimates of $4.28 by $0.01. The business had revenue of $15.86 billion during the quarter, compared to analyst estimates of $15.63 billion. HCA Healthcare had a net margin of 9.32% and a negative return on equity of 12,765.76%. HCA Healthcare’s revenue was up 7.0% compared to the same quarter last year. During the same period last year, the business earned $4.21 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 18.44 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be issued a $0.60 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $2.40 annualized dividend and a yield of 0.94%. HCA Healthcare’s payout ratio is 11.81%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on HCA shares. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, September 12th. Royal Bank of Canada restated an “outperform” rating and set a $315.00 price objective on shares of HCA Healthcare in a report on Wednesday, September 13th. 1-800-FLOWERS.COM reissued a “maintains” rating on shares of HCA Healthcare in a report on Wednesday, June 28th. VNET Group reiterated a “maintains” rating on shares of HCA Healthcare in a research report on Wednesday, June 28th. Finally, Barclays upped their price target on shares of HCA Healthcare from $275.00 to $300.00 in a report on Wednesday, June 28th. Two equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $310.86.

Insider Activity

In related news, SVP Jeffrey E. Cohen sold 1,500 shares of the stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $270.00, for a total transaction of $405,000.00. Following the transaction, the senior vice president now owns 4,414 shares in the company, valued at $1,191,780. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, SVP Kathryn A. Torres sold 5,204 shares of the business’s stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $269.12, for a total transaction of $1,400,500.48. Following the completion of the sale, the senior vice president now directly owns 19,760 shares in the company, valued at $5,317,811.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jeffrey E. Cohen sold 1,500 shares of the stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $270.00, for a total transaction of $405,000.00. Following the completion of the sale, the senior vice president now directly owns 4,414 shares of the company’s stock, valued at $1,191,780. The disclosure for this sale can be found here. Insiders have sold a total of 9,620 shares of company stock valued at $2,592,820 in the last 90 days. 1.60% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.